Metacrine Inc. (MTCR) Social Stream
Metacrine Inc (MTCR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Metacrine Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 46 weeks, MTCR's average price target has gone down $19.
MTCR reports an average of 350.44% for its upside potential over the past 39 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MTCR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Metacrine Inc fares relative to all US stocks, note that its average analyst price target is higher than 1.08% of that group.
- In the context of all US stocks, Metacrine Inc's variance in analysts' estimates is lower than -256.39% of them.
- MTCR has a higher number of analysts covering the stock than 81.24% of Pharmaceutical Products stocks.
- MTCR has a greater upside potential (average analyst target price relative to current price) than 238.34% of Healthcare stocks.
Make investment decisions regarding MTCR using the data that counts. Try POWR Ratings for free.